Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
424B4	Sep 3, 2020	424B4
POS EX	Sep 2, 2020	POS EX
EFFECT	Sep 1, 2020
S-1MEF	Sep 1, 2020	S-1MEF
CORRESP	Aug 31, 2020
CORRESP	Aug 31, 2020
S-1	Aug 31, 2020	FORM S-1
3	Aug 27, 2020	FORM 3
UPLOAD	Aug 27, 2020
424B3	Aug 25, 2020	424B3
8-K	Aug 25, 2020	FORM 8-K
424B3	Aug 21, 2020	424B3
8-K	Aug 21, 2020	8-K
DRS	Aug 19, 2020
424B3	Aug 12, 2020	424B3
10-Q	Aug 12, 2020	10-Q
8-K	Aug 12, 2020	8-K
DEFA14A	Jul 9, 2020	DEFA14A
DEF 14A	Jul 9, 2020	DEF 14A
S-8	Jun 29, 2020	S-8
424B3	Jun 29, 2020	424B3
10-K	Jun 29, 2020	10-K
8-K	Jun 29, 2020	8-K
25-NSE	Jun 15, 2020
4	May 18, 2020	FORM 4 SUBMISSION

← Newer Page 20 of 26 · 646 filings Older →